Other Issues:
previous
|
next
|
latest
|
archive
Volume 5(Suppl 5); 2003
Introduction
New Perspectives on Benign Prostatic Hyperplasia
Herbert Lepor
Rev Urol.
2003;
5
(Suppl 5)
: S1–S2.
PMCID:
PMC1502360
|
Full Text
|
PDF–50K
|
New Perspectives on BPH
Clinical Evaluation of Benign Prostatic Hyperplasia
Kevin T McVary
Rev Urol.
2003;
5
(Suppl 5)
: S3–S11.
PMCID:
PMC1502362
|
Abstract
|
Full Text
|
PDF–114K
|
5-α-Reductase Inhibitors Prevent the Progression of Benign Prostatic Hyperplasia
Claus G Roehrborn
Rev Urol.
2003;
5
(Suppl 5)
: S12–S21.
PMCID:
PMC1502358
|
Abstract
|
Full Text
|
PDF–170K
|
Long-Term Experience With 5-α-Reductase Inhibitors
E. Darracott Vaughan, Jr
Rev Urol.
2003;
5
(Suppl 5)
: S22–S27.
PMCID:
PMC1502364
|
Abstract
|
Full Text
|
PDF–95K
|
Landmark Studies Impacting the Medical Management of Benign Prostatic Hyperplasia
Herbert Lepor
Rev Urol.
2003;
5
(Suppl 5)
: S28–S35.
PMCID:
PMC1502363
|
Abstract
|
Full Text
|
PDF–131K
|
The Medical Therapy of Prostatic Symptoms Study: What Will We Learn?
Kevin M Slawin
Rev Urol.
2003;
5
(Suppl 5)
: S36–S41.
PMCID:
PMC1502359
|
Abstract
|
Full Text
|
PDF–79K
|
A Primary Care Physician’s Perspective on Benign Prostatic Hyperplasia
Louis Kuritzky
Rev Urol.
2003;
5
(Suppl 5)
: S42–S48.
PMCID:
PMC1502361
|
Abstract
|
Full Text
|
PDF–77K
|
Other Issues:
previous
|
next
|
latest
|
archive